Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Siti Aminah Abdul Rahim"'
Autor:
Morgane Sanzey, Siti Aminah Abdul Rahim, Anais Oudin, Anne Dirkse, Tony Kaoma, Laurent Vallar, Christel Herold-Mende, Rolf Bjerkvig, Anna Golebiewska, Simone P Niclou
Publikováno v:
PLoS ONE, Vol 10, Iss 5, p e0123544 (2015)
Major efforts have been put in anti-angiogenic treatment for glioblastoma (GBM), an aggressive and highly vascularized brain tumor with dismal prognosis. However clinical outcome with anti-angiogenic agents has been disappointing and tumors quickly d
Externí odkaz:
https://doaj.org/article/2ff02bf76eb6441fad18cfa6d4aeb05a
Autor:
Kjell Petersen, Uros Rajcevic, Siti Aminah Abdul Rahim, Inge Jonassen, Karl-Henning Kalland, Connie R Jimenez, Rolf Bjerkvig, Simone P Niclou
Publikováno v:
PLoS ONE, Vol 8, Iss 7, p e68288 (2013)
A key challenge in the data analysis of biological high-throughput experiments is to handle the often low number of samples in the experiments compared to the number of biomolecules that are simultaneously measured. Combining experimental data using
Externí odkaz:
https://doaj.org/article/35e1c664b0eb4b1b99ff9db9e19c5c1a
Publikováno v:
Expert Opinion on Therapeutic Targets. 15:1227-1239
Glioblastoma remains a highly aggressive primary brain cancer with very poor prognosis. The detection of mutations in the metabolic enzyme isocitrate dehydrogenase in gliomas, has broadened our view of tumourigenic mechanisms. Together with renewed a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2354716c5aa54244893821b833b771cc
https://doi.org/10.1517/14728222.2011.588211
https://doi.org/10.1517/14728222.2011.588211
Autor:
Howard Y. Chang, Evan Noch, Markus J. Bookland, Kathrin Geiger, Joanna J. Phillips, Janine M. Lupo, Kamel Khalili, Simone P. Niclou, Anita B. Hjelmeland, L. Karl Olson, Ping Huang, Kenneth Schwartz, Kah Suan Lim, Antoinette Price, Georgina Perez-Liz, Sarah M. Woods, John C. Kappes, Charles G. Eberhart, Morgane Sanzey, Dana A M Mustafa, Gelareh Zadeh, Aaron E. Robinson, Alessia Lodi, Dietmer Krex, Jeremy N. Rich, Sigrid M. A. Swagemakers, Justin D. Lathia, Candece L. Gladson, Graeme Eisenhofer, Brent A. Orr, Siti Aminah Abdul Rahim, Johan M. Kros, Sergio Pina-Oviedo, Kah Jing Lim, Alenoush Vartanian, Jennifer Gordon, Russel O. Pieper, Eli E. Bar, Robert M. Danforth, Wei M. Liu, John M. Heddleston, Rolf Bjerkvig, Sabrina M. Ronen, Myriam M. Chaumeil, Amy S. Nowacki, Mirko Peitzsch, David L. Schonberg, Hikari A. I. Yoshihara, Luis Del Valle, Clark W. Distelhorst, Tareq A. Juratli, Sanjay K. Singh, Peter J. van der Spek, Gabriele Schackert
Publikováno v:
Neuro-Oncology. 14:vi53-vi55
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8ab16862dfca7ea1ee0778f70bf1705e
https://doi.org/10.1093/neuonc/nos226
https://doi.org/10.1093/neuonc/nos226
Autor:
Karl-Henning Kalland, Siti Aminah Abdul Rahim, Connie R. Jimenez, Kjell Petersen, Inge Jonassen, Uros Rajcevic, Rolf Bjerkvig, Simone P. Niclou
Publikováno v:
PLoS ONE, 8(7):e68288. Public Library of Science
Petersen, K, Rajcevic, U, Rahim, S A A, Jonassen, I, Kalland, K H, Jimenez, C R, Bjerkvig, R & Niclou, S P 2013, ' Gene Set Based Integrated Data Analysis Reveals Phenotypic Differences in a Brain Cancer Model ', PLoS ONE, vol. 8, no. 7, e68288 . https://doi.org/10.1371/journal.pone.0068288
PLoS ONE, Vol 8, Iss 7, p e68288 (2013)
PLoS ONE
Petersen, K, Rajcevic, U, Rahim, S A A, Jonassen, I, Kalland, K H, Jimenez, C R, Bjerkvig, R & Niclou, S P 2013, ' Gene Set Based Integrated Data Analysis Reveals Phenotypic Differences in a Brain Cancer Model ', PLoS ONE, vol. 8, no. 7, e68288 . https://doi.org/10.1371/journal.pone.0068288
PLoS ONE, Vol 8, Iss 7, p e68288 (2013)
PLoS ONE
A key challenge in the data analysis of biological high-throughput experiments is to handle the often low number of samples in the experiments compared to the number of biomolecules that are simultaneously measured. Combining experimental data using
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9b526906168d0e6bb5055af49e6d851a
https://research.vumc.nl/en/publications/be09691c-1960-4570-a1d0-51a4972f9beb
https://research.vumc.nl/en/publications/be09691c-1960-4570-a1d0-51a4972f9beb
Autor:
Siti Aminah Abdul Rahim, Hrvoje Miletic, Torfinn Taxt, Anais Oudin, Ingrid Moen, Simone P. Niclou, Cecilie Brekke Rygh, Fred Fack, Jian Wang, Linda Elin Birkhaug Stuhr, Rolf Bjerkvig, Morgane Sanzey, Michal Bartoš, Mikael Johansson, Olivier Keunen, Frits Thorsen, Daniel Stieber, Radovan Jirik
Bevacizumab, an antibody against vascular endothelial growth factor (VEGF), is a promising, yet controversial, drug in human glioblastoma treatment (GBM). Its effects on tumor burden, recurrence, and vascular physiology are unclear. We therefore dete
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e37c9c347bf94abdba6a2ec17b30381e
https://europepmc.org/articles/PMC3048093/
https://europepmc.org/articles/PMC3048093/